Spike Gene Target Failure Among RT-PCR Positive SARS-CoV-2 Samples in Dhaka City During Early Variant Waves
Spike Gene Target Failure among RT-PCR positive SARS-CoV-2
DOI:
https://doi.org/10.3329/jopsom.v44i1.88181Keywords:
SARS-CoV-2, COVID-19, RT-PCRAbstract
Background: Real time RT-PCR is a widely used method for detecting SARS-CoV-2, the causative agent of COVID-19 infection. A phenomenon termed ‘spike gene target failure’ (SGTF) has been reported in certain SARS-CoV-2 lineages, in which there is failure to detect the spike (S) gene target in samples that are positive for other RT-PCR targets, which occurs due to a deletion of six nucleotides in the spike gene (69-70del). The SGTF trait has been validated as a reliable surrogate marker for presence of 69-70del in the viral genome. We retrospectively determined the prevalence of SGTF trait among COVID-19 positive samples in Dhaka city.
Methods: The study was conducted in the department of Virology at National Institute of Laboratory Medicine and Referral Center (NILMRC), Dhaka between November 2020 and June 2021. A total of 5,259 nasopharyngeal and oropharyngeal swab samples that tested positive for SARS-CoV-2 with TaqPath COVID-19 Combo PCR kit, were screened for the SGTF marker. SGTF was defined as the non-detection of S-gene-target in samples that were positive for both N and ORF1ab targets with Ct values ≤30.
Results: Among 5,259 PCR-positive samples, 144 (2.74%; 95% CI: 2.30%, 3.20%)) showed SGTF trait in our study. The peak SGTF detection rate was observed in February 2021 (10.77%; p<0.0031), which corresponded with the widely-reported circulation of Alpha variant in Bangladesh that characteristically displays 69-70del in the spike gene. Sequencing was not performed, which limited lineage confirmation.
Conclusion: An abrupt increase in SGTF marker detection at PCR laboratories should be investigated thoroughly to enable the prompt identification of emerging SARS-CoV-2 lineages carrying 69–70 deletion.
JOPSOM 2025; 44(1): 18-23
Downloads
0
0
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Aunta Melan, Towfiq Mahmud, Arifa Akram, Md Bayzid Bin Monir, Tasnim Nafisa

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright Notice
Authors who publish in the Journal of Preventive and Social Medicine (JOPSOM) agree to the following terms that:
- Authors retain copyright and grant the Journal of Preventive and Social Medicine (JOPSOM) the right of first publication of the work.

Articles in the Journal of Preventive and Social Medicine (JOPSOM) are Open Access articles published under the Creative Commons CC BY-NC License Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). This license permits Share — copy and redistribute the material in any medium or format and Adapt — remix, transform, and build upon the material.